guilherme henrique espíndola efeitos adversos dos ... - UFSC

More documents

Recommendations

Info

12. Martinez E, Tuset M, Milinkovic A, Miro JM, Gatell JM. Management ofdyslipidaemia in HIV-infected patients receiving antiretroviral therapy. InfectiousDiseases, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.13. Melvin AJ, Lennon S, Mohan KM, Purnell JQ. Metabolic abnormalities in HIV type1-infected children treated and not treated with protease inhibitors. AIDS Res HumRetroviruses 2001;17: 1117-23.14. Carr A, Cooper DA. Adverse effects of ARVT. Lancet 2000;356: 1423-3015. Lee Ecc, Walmsley S. Fantus IG. New-onset diabetes mellitus associated withprotease inhibitor therapy in HIV positive patient. Case of report and rewiew. CMAJ1999;161(2): 161-416. Walli R, Herfort O, Michl GM, Demant T, Jager H, Dieterle C, et al. Treatment withprotease inhibitors associated with peripheral insulin resistance and impaired oralglucose tolerance in HIV -1- infected patients. AIDS 1998;12: F167-73.17. Dube MP. Disorders of glucose metabolism in patients infected with humanimmunodeficiency vírus. Clin. Infec.Disease 2000;31: 1467-75.18. Grace A, McComsey and Ethan Leonard, Metabolic complications of HIV therapyin children. AIDS 2004;18: 1753-68.19. Mueller BU, Nelson RPJr, Sleasman J, Zuckeman J, HeathChiozzi M, Steinberg SM,et al. A phase I/II study of the protease inhibitor ritonavir in children with humanimmunodeficiency vírus infection. Pediatrics 1998;101: 335 –43.20. Prevalence of adverse events associated with potent antiretroviral treatment: SWISSHIV Cohort Study. The Lancet 2001 Oct 20;358: 1322-27.21. Unexpected drug interactions and adverse events with antiretroviral drugs. TheLancet 2004 Jul 3;364: 8-10.22. Murphy R. Defining the Toxicity Profile of Nevirapine and Other AntiretroviralDrugs. JAIDS 2003;34: S15-9.23. Protease inhibitors may increase blood glucose in HIV patients. Washington, DC:Food and Drug Administration, 1997.24. Grunfeld C, Kotler DP, Hamadeh R, Tierney A, Wang J, Pierson RN.Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1989;86:27-31.
25. Cheseaux JJ, Jotterand V, Aebi C, Gnehm H, Kind C, Nadal D, et al.Hyperlipidemia in HIV-infected children treated with protease inhibitors: relevance ofcardiovascular diseases. J Acquir ImmuneDefic Syndr 2002;30: 288-93.26. Dubé MP, Stein JH, Aberg JA, Fichtenbaum CJ, Gerber JG, Tashima KT, et al.Guidelines for the evaluation and management of dyslipidemia in humanimmunodeficiency vírus (HIV)-infected adults receiving antiretroviral therapy:recommendations of the HIV Medical Association of the Infectious Disease Society ofAmérica and the Adult AIDS Clinical Trial Group. Clin Infect Dis 2003;37: 613-27.27. The Expert Panel of the National Cholesterol Education Program. Executivesummary of the third report of the National Cholesterol Education Program (NCEP)Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults(adult treatment panel III) JAMA 2001;285: 2486-97.28. Lima ALM, Kiffer CR, Uip D, Oliveira MS, Leite OM. Perguntas e RespostasHIV/AIDS: uma equipe multidisciplinar da USP tira suas principais dúvidas. São Paulo:Atheneu; 1996.
Page 1 and 2: GUILHERME HENRIQUE ESPÍNDOLAEFEITO
Page 3 and 4: Espíndola, Guilherme HenriqueEfeit
Page 5 and 6: AGRADECIMENTOSMeus sinceros agradec
Page 7 and 8: AZT na TARV utilizada. As crianças
Page 9 and 10: GLOSSÁRIO1. HIV - Human Immunodefi
Page 11 and 12: 1. INTRODUÇÃONo decorrer da déca
Page 13 and 14: Enquanto o desenvolvimento de novos
Page 15 and 16: 2. OBJETIVOO objetivo do presente e
Page 17 and 18: c) Recusa dos responsáveis na part
Page 19 and 20: 4. RESULTADOSNo período compreendi
Page 21 and 22: 4.1 Níveis séricos de Colesterol
Page 23 and 24: 44,6168. Esta comparação não dem
Page 25 and 26: Os valores médios de amilase com T
Page 27 and 28: 39,1726. As crianças que não usav
Page 29 and 30: Tabela 6 - Média de valores bioqu
Page 31 and 32: Tabela 8 - Comparação entre Níve
Page 33 and 34: DISCUSSÃOUma vez não havendo uma
Page 35 and 36: drogas da classe dos ITRN. Vinte e
Page 37 and 38: também infectados pelo HIV pode fa
Page 39 and 40: esquema da TARV, obtiveram um valor
Page 41: REFERÊNCIAS BIBLIOGRÁFICAS1. Prog

guilherme henrique espíndola efeitos adversos dos ... - UFSC

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?